Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04234568
Title Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054 United States Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field